NCT00003894View on ClinicalTrials.gov

Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 1999

Primary Completion Date

January 31, 2000

Study Completion Date

June 30, 2002

Conditions
Graft Versus Host DiseaseUnspecified Adult Solid Tumor, Protocol SpecificUnspecified Childhood Solid Tumor, Protocol Specific
Interventions
DRUG

thalidomide

Trial Locations (10)

53226

Cancer Center of the Medical College of Wisconsin, Milwaukee

Medical College of Wisconsin, Milwaukee

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

77030

University of Texas - MD Anderson Cancer Center, Houston

78234

Brooke Army Medical Center, Fort Sam Houston

72202-3591

Arkansas Children's Hospital, Little Rock

66160-7357

University of Kansas Medical Center, Kansas City

70112-2822

Louisiana State University School of Medicine, New Orleans

14263-0001

Roswell Park Cancer Institute, Buffalo

75235-9154

Simmons Cancer Center - Dallas, Dallas

All Listed Sponsors
lead

Roswell Park Cancer Institute

OTHER

NCT00003894 - Thalidomide in Treating Patients With Chronic Graft-Versus-Host Disease Following Bone Marrow Transplant | Biotech Hunter | Biotech Hunter